96 results on '"Eastell, R."'
Search Results
2. Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis
3. Real-world bone turnover marker use: impact on treatment decisions and fracture
4. Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study
5. Harmonization of commercial assays for PINP; the way forward
6. Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis
7. Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
8. Discordant pattern of peripheral fractures in diabetes: a meta-analysis on the risk of wrist and ankle fractures
9. Diagnosis and management of bone fragility in diabetes: an emerging challenge
10. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density
11. Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study
12. Stop (mis)classifying fractures as high- or low-trauma or as fragility fractures
13. Authors’ response to KD Stathopoulos regarding “Stop (Mis)classifying Fractures as High or Low Trauma or as Fragility Fractures”
14. Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture
15. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
16. Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users
17. International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates
18. The relationship between maternal self-efficacy, compliance and outcome in a trial of vitamin D supplementation in pregnancy
19. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus
20. Patient-specific finite element estimated femur strength as a predictor of the risk of hip fracture: the effect of methodological determinants
21. Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia
22. Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
23. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
24. Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over
25. Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review
26. The impact of glucocorticoid therapy on trabecular bone score in older women
27. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study
28. TBS result is not affected by lumbar spine osteoarthritis
29. Greater seasonal cycling of 25-hydroxyvitamin D is associated with increased parathyroid hormone and bone resorption
30. Distribution of bone density and cortical thickness in the proximal femur and their association with hip fracture in postmenopausal women: a quantitative computed tomography study
31. Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng
32. Adherence to raloxifene therapy: assessment methods and relationship with efficacy
33. Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice
34. Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial
35. Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study
36. Treatment failure in osteoporosis
37. An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis
38. A European multicenter comparison of quantitative ultrasound measurement variables: The OPUS study
39. Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study
40. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
41. Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
42. Endogenous Estradiol and The Risk of Incident Fracture in Postmenopausal Women: The OPUS Study
43. Prevalence of non-fracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound study
44. Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS)
45. Effects of calcium-fortified ice cream on markers of bone health
46. Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide
47. Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
48. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
49. International variation in proximal femur bone mineral density
50. Significant differences in UK and US female bone density reference ranges
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.